J Aschan - Concepedia

Author

J Aschan

Karolinska Institutet

Also Known As

J Aschan, J. Aschan, JOHAN ASCHAN, Johan Aschan

141

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital Integrated Cardio Metabolic Centre Stockholm University College of Music Education

About

J Aschan is an author at Karolinska Institutet specializing in medicine, transplantation, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	39	2.1K
2	Blood Transplantation	10	11	505
3	Health Sciences	4	4	318
4	Allergy	1	1	10
5	Biomedical Engineering	1	1	67

J Aschan

Publications

5.9K

Citations

H-Index

Page 1

	Year	Citations
Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease Olle Ringdén, Mehmet Uzunel, Ida Rasmusson, Transplantation	2006	1.1K
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis Stefan Carlens, Olle Ringdén, Mats Remberger, Bone Marrow Transplantation Graft-versus-host DiseaseTransplantationAutoimmune DiseaseMarrow TransplantationBone Marrow Failure	1998	208
Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Olle Ringdén, Mats Remberger, U Persson, PubMed	1995	181
RESULTS OF DIFFERENT STRATEGIES FOR REDUCING CYTOMEGALOVIRUS-ASSOCIATED MORTALITY IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS1 Per Ljungman, J Aschan, Ilona Lewensohn‐Fuchs, Transplantation	1998	177
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care Britt‐Marie Svahn, Mats Remberger, Karl-Erik Myrbäck, Blood	2002	157
Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology Moustapha Hassan, Göran Berg, A N Békássy, Cancer Chemotherapy and Pharmacology PharmacologyHigh-dose BusulphanClinical PharmacologyPharmacotherapyMedicine	1991	155
A new method for in vitro expansion of cytotoxic human CD3−CD56+ natural killer cells Stefan Carlens, Mari Gilljam, Benedict J. Chambers, Human Immunology Cell TherapyMedicineImmunologyCell Replacement TherapyCell Biology	2001	142
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation Jonas Mattsson, Mehmet Uzunel, L Tammik, Leukemia Hematological MalignancySensitive PredictorTransplantationMarrow TransplantationMyelodysplastic Syndrome	2001	133
Influenza A in Immunocompromised Patients Per Ljungman, John Andersson, J Aschan, Clinical Infectious Diseases	1993	129
Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation P Ljungman, I Lewensohn-Fuchs, V Hammarstrom, Blood	1994	128

Page 1